OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 152
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 152
Showing 1-25 of 152 citing articles:
NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 141
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 141
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 121
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 121
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
Kritika Engle, Gautam Kumar
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114542-114542
Closed Access | Times Cited: 109
Kritika Engle, Gautam Kumar
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114542-114542
Closed Access | Times Cited: 109
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 107
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 107
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 88
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 88
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 76
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 76
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 54
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 54
Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance
Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 29-53
Closed Access | Times Cited: 44
Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 29-53
Closed Access | Times Cited: 44
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ferdos Faghihkhorasani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 457-479
Closed Access | Times Cited: 22
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ferdos Faghihkhorasani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 457-479
Closed Access | Times Cited: 22
Research progress of organic photothermal agents delivery and synergistic therapy systems
Yuan Li, Haolong Qi, Yingjie Geng, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 234, pp. 113743-113743
Closed Access | Times Cited: 16
Yuan Li, Haolong Qi, Yingjie Geng, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 234, pp. 113743-113743
Closed Access | Times Cited: 16
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 61
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 52
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 52
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
Shuo Deng, Hin Chong Leong, Arpita Datta, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1652-1652
Open Access | Times Cited: 48
Shuo Deng, Hin Chong Leong, Arpita Datta, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1652-1652
Open Access | Times Cited: 48
Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
Elaine Stur, Sara Corvigno, Mingchu Xu, et al.
iScience (2022) Vol. 25, Iss. 3, pp. 103923-103923
Open Access | Times Cited: 47
Elaine Stur, Sara Corvigno, Mingchu Xu, et al.
iScience (2022) Vol. 25, Iss. 3, pp. 103923-103923
Open Access | Times Cited: 47
Targeting PI3K/Akt signaling in prostate cancer therapy
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 43
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 43
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
The interactions of docetaxel with tumor microenvironment
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110214-110214
Closed Access | Times Cited: 37
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110214-110214
Closed Access | Times Cited: 37
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, et al.
Environmental Research (2023) Vol. 227, pp. 115722-115722
Closed Access | Times Cited: 31
Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, et al.
Environmental Research (2023) Vol. 227, pp. 115722-115722
Closed Access | Times Cited: 31
The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer
Safoora Pordel, Motahare Khorrami, Fatemeh Saadatpour, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154729-154729
Open Access | Times Cited: 30
Safoora Pordel, Motahare Khorrami, Fatemeh Saadatpour, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154729-154729
Open Access | Times Cited: 30
Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Mehrdad Hashemi, Niloufar Nadafzadeh, Mohammad Hassan Imani, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 28
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 28
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 23
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 23
Mulberry Biomass-Derived Nanomedicines Mitigate Colitis through Improved Inflamed Mucosa Accumulation and Intestinal Microenvironment Modulation
Wenjing Yang, Ya Ma, Haiting Xu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 23
Wenjing Yang, Ya Ma, Haiting Xu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 23
Insights into molecular mechanisms of chemotherapy resistance in cancer
Animesh Kar, Shivam Agarwal, Agrata Singh, et al.
Translational Oncology (2024) Vol. 42, pp. 101901-101901
Open Access | Times Cited: 11
Animesh Kar, Shivam Agarwal, Agrata Singh, et al.
Translational Oncology (2024) Vol. 42, pp. 101901-101901
Open Access | Times Cited: 11
